Bad Drug List
Home / Bad Drugs / Raxar

Raxar

Raxar oral fluoroquinolone antibiotic was prescribed to an estimated 2.65 million patients from when Raxar was first marketed in August 1997 until the October 1997 recall. Raxar was intended to treat a variety of infections, such as pneumonia, bronchitis, and some sexually transmitted infections. The antibiotic has been linked to serious side effects including Raxar prolonging the heart's QT interval that can lead to ventricular arrhythmia that can become fatal.

Raxar manufacturer, GlaxoWellcome has been in violation of FDA regulations for misleading information as well. The FDA required any Raxar promotional materials to be discontinued that were in violation in addition to writing a letter containing the company's intent to comply with the FDA's requests regarding Raxar. If you would like more information regarding Raxar please contact us.

MedLine Plus Drug Information - Guide to prescription and over-the-counter medications provided by the United States Pharmacopeia.

Grepafloxacin (Raxar) - Usage, effects and cautions about Raxar.